References
- De Clercq E. New approaches toward anti-HIV chemotherapy. j Med Chem 2005;48:1297–1313.
- Geffen N. Beyond HAART: scientists and activists need to work together. Lancet 2009;374:860–861.
- Dayam R, Gundla R, Al-Mawsawi LQ, Neamati N. HIV-1 integrase inhibitors: 2005-2006 update. Med Res Rev 2008;28:118–154.
- Zhao G, Wang C, Liu C, Lou H. New developments in diketo-containing inhibitors of HIV-1 integrase. Mini Rev Med Chem 2007;7:707–725.
- Johnson AA, Marchand C, Pommier Y. HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial. Curr Top Med Chem 2004;4:1059–1077.
- Fesen MR, Kohn KW, Leteurtre F, Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci usa 1993;90:2399–2403.
- Ho CC, Lin SS, Chou MY, Chen FL, Hu CC, Chen CS et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. j Antimicrob Chemother 2005;56:372–379.
- Neamati N, Lin Z, Karki RG, Orr A, Cowansage K, Strumberg D et al. Metal-dependent inhibition of HIV-1 integrase. j Med Chem 2002;45:5661–5670.
- Tchertanov L, Mouscadet JF. Target recognition by catechols and beta-ketoenols: potential contribution of hydrogen bonding and Mn/Mg chelation to HIV-1 integrase inhibition. j Med Chem 2007;50:1133–1145.
- Zhao H, Neamati N, Mazumder A, Sunder S, Pommier Y, Burke TR Jr. Arylamide inhibitors of HIV-1 integrase. j Med Chem 1997;40:1186–1194.
- King PJ, Ma G, Miao W, Jia Q, McDougall BR, Reinecke MG et al. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. j Med Chem 1999;42:497–509.
- Supuran CT, Innocenti A, Mastrolorenzo A, Scozzafava A. Antiviral sulfonamide derivatives. Mini Rev Med Chem 2004;4:189–200.
- Fisher TE, Kim B, Staas DD, Lyle TA, Young SD, Vacca JP et al. 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors. Bioorg Med Chem Lett 2007;17:6511–6515.
- Marchand C, Maddali K, Métifiot M, Pommier Y. HIV-1 IN inhibitors: 2010 update and perspectives. Curr Top Med Chem 2009;9:1016–1037.
- Serrao E, Odde S, Ramkumar K, Neamati N. Raltegravir, elvitegravir, and metoogravir: the birth of “me-too” HIV-1 integrase inhibitors. Retrovirology 2009;6:25.
- Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y et al. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: part II. integrase inhibition. Biochem Biophys Res Commun 2007;354:879–884.
- Wu B, Zhou L, Cai HH. Synthesis and neuroprotective properties of novel cinnamide derivatives. Chinese Chem Lett 2008;19:1163–1166.
- Andrus MB, Liu J, Meredith EL, Nartey E. Synthesis of resveratrol using a direct decarbonylative Heck approach from resorcylic acid. Tetrahedron Lett 2003;44:4819–4822.
- Dayam R, Al-Mawsawi LQ, Zawahir Z, Witvrouw M, Debyser Z, Neamati N. Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors. J Med Chem 2008;51:1136–1144.